Network pharmacology and molecular docking identify eugenol as a lead compound targeting visceral leishmaniasis pathways with nanotechnology-driven drug design and nanoscale interaction analysis. ETN [Internet]. 2026 Jul. 15 [cited 2026 Jul. 15];10(3):1449-68. Available from: https://etnano.com/index.php/journal/article/view/294